In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis
about
Heparan sulfate and heparin interactions with proteinsPathophysiology of heparan sulphate: many diseases, few drugsTowards understanding the roles of heparan sulfate proteoglycans in Alzheimer's diseasePrion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic targetAccelerated resolution of AA amyloid in heparanase knockout mice is associated with matrix metalloproteasesStructure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host InsultsHeparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.Role of heparanase on hepatic uptake of intestinal derived lipoprotein and fatty streak formation in mice.Heparin induces harmless fibril formation in amyloidogenic W7FW14F apomyoglobin and amyloid aggregation in wild-type protein in vitro.Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid AEx vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial functionThe heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.Noncerebral Amyloidoses: Aspects on Seeding, Cross-Seeding, and Transmission.Proteomic analysis of highly prevalent amyloid A amyloidosis endemic to endangered island foxesMammalian heparanase: what is the message?Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.Heparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein.Observations in APP bitransgenic mice suggest that diffuse and compact plaques form via independent processes in Alzheimer's disease.Heparanase powers a chronic inflammatory circuit that promotes colitis-associated tumorigenesis in mice.Heparan sulfate proteoglycans.Suppression of amyloid beta A11 antibody immunoreactivity by vitamin C: possible role of heparan sulfate oligosaccharides derived from glypican-1 by ascorbate-induced, nitric oxide (NO)-catalyzed degradation.In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.Preclinical Validation of the Heparin-Reactive Peptide p5+14 as a Molecular Imaging Agent for Visceral AmyloidosisSPECT imaging of peripheral amyloid in mice by targeting hyper-sulfated heparan sulfate proteoglycans with specific scFv antibodies.Transgenic over-expression of mammalian heparanase delays prion disease onset and progression.Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier functionHeparan sulfate proteoglycans mediate Aβ-induced oxidative stress and hypercontractility in cultured vascular smooth muscle cellsDrug Insight: emerging therapies for amyloidosis.The workings of the amyloid diseases.Heparan sulphate biosynthesis and disease.Heparanase: one molecule with multiple functions in cancer progression.Animal models of human amyloidoses: are transgenic mice worth the time and trouble?Increased Granulocyte Heparanase Activity in Neutrophils from Patients with Lupus Nephritis and Idiopathic Membranous Nephropathy.Amyloid and the GI tract.Localized amyloids important in diseases outside the brain--lessons from the islets of Langerhans and the thoracic aorta.Review of eprodisate for the treatment of renal disease in AA amyloidosis.Pathophysiology and treatment of systemic amyloidosis.Immunoglobulin light chain amyloidosis.Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors.The effect of glycosaminoglycans (GAGs) on amyloid aggregation and toxicity.
P2860
Q26796383-5BAEAF3F-9675-44B2-8139-03031E48D26AQ26823840-0F24AEFA-B9DE-4D4D-A8A5-4B690AC23F90Q26992202-D41DFC74-8855-441D-912F-B81DE628F717Q27021159-664E3310-2A54-4F13-BE69-D84897F46FE6Q27300115-0DE7CFFC-FCC9-4D90-B81A-2DB298F70C04Q33604867-134909FE-365E-4B84-BB8B-C8860BCD0A75Q33795144-93D2F862-654C-401D-98B5-B6E7FA37C2C6Q33869288-56A3B15D-FE97-4A99-ACB7-3E1A48701CB7Q33968252-17C4A68B-20CF-49FE-8E4E-0B5BC98D4FACQ33993673-BD841466-E08B-4D35-9EF0-2B0D492E80CCQ34172143-7DD50ABD-8700-4A4F-A5CF-8C25512CAAC4Q34412830-66C699C0-EC29-4D7C-B136-A2C4273778B9Q34549794-F25B4F98-1448-4A08-9FB4-E0AE4DF018CBQ34579925-7A9370CB-02D5-4303-88BC-473650159520Q34652072-DF56FE2E-08DF-4DFC-AE4F-0A9DD528063AQ34679899-95DE73B6-3395-4E46-96B6-332E7822835AQ34805156-ECD20D87-4478-494C-B783-95AD9F272E33Q34838288-D32CB35B-7A61-4FEA-8B7A-98A1B85A9500Q34876266-18D33414-F7DF-4ADE-BBDB-577164C72DC5Q35059448-CC321D4A-2336-4A7F-AC06-AC8E3C5B2E68Q35144959-729F7185-5588-44EA-8574-C7ED699CFFC2Q35180876-205BC239-3F0E-4728-9B20-2A4CC57CC7E7Q35639988-0C67A427-2D66-42C2-AFC8-298B61AFDBA1Q35656129-C250B581-7830-4DFC-8619-4EDA3F3DE93EQ35940703-F07C6DDA-6A0A-48EE-B885-118C677F05B0Q36227233-D9D5203B-6D81-4F41-9A87-ACABA4655E81Q36489864-35C7374A-796A-49C6-A798-CBDA254A050FQ36577160-EF26695C-3804-4A3D-B573-6AF63C66349BQ36801112-9D632847-A404-4DDC-8A52-773689092CBCQ37119533-4CA54BA2-1E3D-450C-8056-2CF8F4F08466Q37228578-369B0F40-3043-4AE5-A625-E41DE8DDA3FBQ37560167-3FE5CD7F-1E8A-47FB-825D-B062C41A3140Q37611235-4A210637-07B3-43F7-A22D-F7CDA0B1B0E7Q37636098-BC92780C-9EA9-4DD3-8A12-5CF2DDEF705EQ37915629-6A347249-8651-4FFA-9D2D-D241335E78FFQ37994670-6837BC5F-C482-4DA3-B2CC-1AE4FE063A46Q38131710-150E0E18-C10E-4D79-BA2F-CA851572B707Q38172295-1E7E1DCA-88EA-4786-8345-19D6BED97312Q38311931-BD62A004-0DC2-437A-97A1-886284697AE2Q38343014-5F62D842-8003-4616-BE32-AF10DE3CBEF8
P2860
In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
In vivo fragmentation of hepar ...... amyloid protein A amyloidosis
@ast
In vivo fragmentation of hepar ...... amyloid protein A amyloidosis
@en
type
label
In vivo fragmentation of hepar ...... amyloid protein A amyloidosis
@ast
In vivo fragmentation of hepar ...... amyloid protein A amyloidosis
@en
prefLabel
In vivo fragmentation of hepar ...... amyloid protein A amyloidosis
@ast
In vivo fragmentation of hepar ...... amyloid protein A amyloidosis
@en
P2093
P2860
P356
P1476
In vivo fragmentation of hepar ...... amyloid protein A amyloidosis
@en
P2093
Eyal Zcharia
Israel Vlodavsky
Jin-Ping Li
Martha L Escobar Galvis
Robert Kisilevsky
Shula Metzger
Xiao Zhang
P2860
P304
P356
10.1073/PNAS.0502287102
P407
P50
P577
2005-04-20T00:00:00Z